Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Analysts are expecting strong performance driven by the robust sales of Lilly's https://joanfkwu256396.nizarblog.com/37805788/analyzing-eli-lilly-s-q3-results